Work

Secukinumab Provides Complete or Almost-Complete Psoriasis Clearance in Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of 4 Phase 3 Trials

Year: 2018

Type: article

Abstract: not available. Disclosures: Study sponsored by Novartis. Copyright 2018 SKIN

Source: SKIN The Journal of Cutaneous Medicine

DOI: 10.25251/skin.2.supp.19

Authors: A Blauvelt, A Armstrong, P Rich, R Kisa, A Guana, X Meng, K Callis Duffin

Language: English

Topic: Psoriasis: Treatment and Pathogenesis

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: diamond

Funders: Novartis Pharmaceuticals Corporation, Novartis Pharma

OpenAlex ID: W2792584756

FWCI: 0.174

Cites:

Cited by: 2

Related to: 10